secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2026-08-28T20:15:18+00:00
Accession:  0001099800-26-000048
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences Strategy VP Donald Bobo to retire by mid-2027; successor search begins
--------------------------------------------------------------------------------

- Donald E. Bobo, Jr., Corporate Vice President of Strategy and Corporate Development, plans to retire by mid-year 2027.
- Board will begin a selection process promptly to identify a successor, with transition expected during 2027.
- Bobo is expected to remain as a consultant with the Company through the end of 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000109980026000048/0001099800-26-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000109980026000048/ew-20260825.htm
  HTML page:      https://secwatch.observer/filing/0001099800-26-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer